$CATX
Perspective Therapeutics, Inc.

2015 Q1 Form 10-Q Financial Statement

#000114420415010049 Filed on February 17, 2015

View on sec.gov

Income Statement

Concept 2015 Q1 2014 Q4 2013 Q4
Revenue $1.158M $1.066M $1.085M
YoY Change 2.1% -1.83% 11.27%
Cost Of Revenue $1.103M $1.104M $1.119M
YoY Change 1.8% -1.41% -1.3%
Gross Profit $55.20K -$37.96K -$33.91K
YoY Change 8.43% 11.97% -78.63%
Gross Profit Margin 4.77% -3.56% -3.12%
Selling, General & Admin $964.8K $841.7K $840.4K
YoY Change 8.86% 0.15% 6.16%
% of Gross Profit 1747.94%
Research & Development $141.4K $140.6K $170.0K
YoY Change -7.95% -17.29% 13.98%
% of Gross Profit 256.17%
Depreciation & Amortization $140.0K $135.2K $180.0K
YoY Change -17.65% -24.9% 0.0%
% of Gross Profit 253.64%
Operating Expenses $1.106M $982.4K $1.010M
YoY Change 6.38% -2.78% 7.4%
Operating Profit -$1.051M -$1.020M -$1.044M
YoY Change 6.27% -2.3% -5.01%
Interest Expense $100.00 $0.00 $86.00
YoY Change -100.0% -100.17%
% of Operating Profit
Other Income/Expense, Net $97.46K $113.4K $117.4K
YoY Change -108.9% -3.44% -313.94%
Pretax Income -$950.0K -$910.0K -$930.0K
YoY Change -54.33% -2.15% -19.13%
Income Tax
% Of Pretax Income
Net Earnings -$953.6K -$907.0K -$927.0K
YoY Change -54.23% -2.16% -19.7%
Net Earnings / Revenue -82.34% -85.11% -85.4%
Basic Earnings Per Share
Diluted Earnings Per Share -$17.31K -$16.58K -$24.25K
COMMON SHARES
Basic Shares Outstanding 54.88M shares 54.87M shares 38.42M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2015 Q1 2014 Q4 2013 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $10.16M $11.38M $4.410M
YoY Change -57.13% 158.05% -0.68%
Cash & Equivalents $1.078M $1.337M $4.415M
Short-Term Investments $9.080M $10.05M
Other Short-Term Assets $220.0K $220.0K $160.0K
YoY Change 4.76% 37.5% -30.43%
Inventory $460.0K $411.4K $426.3K
Prepaid Expenses
Receivables $1.040M $797.4K $917.2K
Other Receivables $10.00K $10.98K $10.00K
Total Short-Term Assets $11.89M $12.83M $5.925M
YoY Change -52.64% 116.47% 3.28%
LONG-TERM ASSETS
Property, Plant & Equipment $660.0K $761.4K $1.349M
YoY Change -44.21% -43.58% -33.48%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $10.15M $10.10M
YoY Change
Other Assets $650.0K $250.9K $262.7K
YoY Change 151.33% -4.49% -12.75%
Total Long-Term Assets $11.69M $11.76M $2.263M
YoY Change 458.63% 419.64% -24.07%
TOTAL ASSETS
Total Short-Term Assets $11.89M $12.83M $5.925M
Total Long-Term Assets $11.69M $11.76M $2.263M
Total Assets $23.58M $24.59M $8.188M
YoY Change -13.31% 200.27% -6.07%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $440.0K $490.0K $430.0K
YoY Change -27.87% 13.95% 10.26%
Accrued Expenses $440.0K $450.0K $420.0K
YoY Change 7.32% 7.14% 40.0%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $880.0K $941.9K $847.3K
YoY Change -13.79% 11.17% 21.59%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $1.110M $1.120M $850.0K
YoY Change -27.45% 31.76% -15.0%
Total Long-Term Liabilities $1.110M $1.120M $850.0K
YoY Change -27.45% 31.76% -15.0%
TOTAL LIABILITIES
Total Short-Term Liabilities $880.0K $941.9K $847.3K
Total Long-Term Liabilities $1.110M $1.120M $850.0K
Total Liabilities $1.988M $2.057M $1.699M
YoY Change -21.93% 21.09% 0.27%
SHAREHOLDERS EQUITY
Retained Earnings -$60.70M -$59.74M -$54.29M
YoY Change 7.67% 10.05% 7.75%
Common Stock $54.88K $54.88K $38.42K
YoY Change 1.3% 42.85% 11.0%
Preferred Stock
YoY Change
Treasury Stock (at cost) $8.390K $8.390K $8.390K
YoY Change 0.0% 0.0% 0.0%
Treasury Stock Shares 13.20K shares 13.20K shares 13.20K shares
Shareholders Equity $21.60M $22.53M $6.489M
YoY Change
Total Liabilities & Shareholders Equity $23.58M $24.59M $8.188M
YoY Change -13.29% 200.27% -6.07%

Cashflow Statement

Concept 2015 Q1 2014 Q4 2013 Q4
OPERATING ACTIVITIES
Net Income -$953.6K -$907.0K -$927.0K
YoY Change -54.23% -2.16% -19.7%
Depreciation, Depletion And Amortization $140.0K $135.2K $180.0K
YoY Change -17.65% -24.9% 0.0%
Cash From Operating Activities -$1.130M -$620.0K -$850.0K
YoY Change 126.0% -27.06% 49.12%
INVESTING ACTIVITIES
Capital Expenditures -$40.00K -$40.00K -$20.00K
YoY Change 100.0%
Acquisitions
YoY Change
Other Investing Activities $920.0K -$70.00K $0.00
YoY Change
Cash From Investing Activities $870.0K -$110.0K -$20.00K
YoY Change 450.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 0.000 -10.00K -10.00K
YoY Change -100.0% 0.0% 0.0%
NET CHANGE
Cash From Operating Activities -1.130M -620.0K -850.0K
Cash From Investing Activities 870.0K -110.0K -20.00K
Cash From Financing Activities 0.000 -10.00K -10.00K
Net Change In Cash -260.0K -740.0K -880.0K
YoY Change -101.35% -15.91% 51.72%
FREE CASH FLOW
Cash From Operating Activities -$1.130M -$620.0K -$850.0K
Capital Expenditures -$40.00K -$40.00K -$20.00K
Free Cash Flow -$1.090M -$580.0K -$830.0K
YoY Change 118.0% -30.12% 45.61%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
us-gaap Description Of New Accounting Pronouncements Not Yet Adopted
DescriptionOfNewAccountingPronouncementsNotYetAdopted
<div id='EdgarSAA123457890000' style="font-family : 'Times New Roman';"> <div> <div class="CursorPointer"> <table cellpadding="0" cellspacing="0" style=" font: 10pt times new roman, times, serif; margin-top: 0; margin-bottom: 0;"> <tr style=" vertical-align: top; text-align: justify;"> <td style=" width: 0in; border-left: none; border-right: none; border-top: none; border-bottom: none;">&#160;</td> <td width="24px" style=" text-align: left; border: none; font-family: 'Times New Roman';"><strong>2.</strong></td> <td style=" text-align: justify; padding-left: 0.25in; font-family: 'times new roman'; border-left: none; border-right: none; border-top: none; border-bottom: none;"><strong>New Accounting Pronouncements</strong></td> </tr> </table> </div> <p style=" font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify;">&#160;</p> <div style=" display: inline; font-size: 13px; font-family: 'Times New Roman', Times, serif; font-variant: normal; font-weight: normal; font-style: normal; text-decoration: none; color: rgb(0, 0, 0);"> <p style=" color: rgb(0, 0, 0); font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0pt 0px; text-align: justify; background-color: white;"><font style=" background-color: white;">In May 2014, the Financial Accounting Standards Board (FASB) issued Accounting Standards Update (ASU) 2014-09, "Revenue from Contracts with Customers" (ASU 2014-09), which supersedes the revenue recognition requirements in FASB Accounting Standards Codification (ASC) Topic 605, "Revenue Recognition". The guidance requires that an entity recognize revenue in a way that depicts the transfer of promised goods or services to customers in the amount that reflects the consideration to which the entity expects to be entitled to in exchange for those goods and services. The guidance will be effective for annual reporting periods beginning after December&#160;15, 2016, including interim periods within that reporting period and is to be applied retrospectively, with early application not permitted. The Company is currently evaluating the new standard and its impact on the Company's consolidated financial statements.&#160;&#160;</font></p> <p style=" color: rgb(0, 0, 0); font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0pt 0px; text-align: justify; text-indent: 0.5in; background-color: white;">&#160;</p> <p style=" color: rgb(0, 0, 0); font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-indent: 0px; text-transform: none; white-space: normal; widows: auto; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0pt 0px; text-align: justify; background-color: white;"><font style=" background-color: white;">In August 2014, the FASB issued ASU No. 2014-15&#151;Presentation of Financial Statements&#151;Going Concern.&#160;&#160; The guidance requires an entity's management to evaluate whether there are conditions or events, considered in the aggregate, that raise substantial doubt about the entity's ability to continue as a going concern within one year after the date that the financial statements are issued (or within one year after the date that the financial statements are available to be issued when applicable).&#160; If conditions or events exist that raise substantial doubt about an entity's ability to continue as a going concern, the guidance requires disclosure in the financial statements.&#160;&#160; The guidance will be effective for the annual period ending after December 15, 2016, and for annual periods and interim periods thereafter. Early application is permitted.&#160; The Company is currently evaluating the new standard and its impact on the Company's consolidated financial statements.</font></p> </div> </div> </div>
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1
P3Y9M29D
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
P4Y4M6D
us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P2Y18D
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P4Y5M5D
us-gaap Cost Of Property Repairs And Maintenance
CostOfPropertyRepairsAndMaintenance
6000 USD
us-gaap Related Party Transaction Selling General And Administrative Expenses From Transactions With Related Party
RelatedPartyTransactionSellingGeneralAndAdministrativeExpensesFromTransactionsWithRelatedParty
6000 USD
us-gaap Related Party Transaction Selling General And Administrative Expenses From Transactions With Related Party
RelatedPartyTransactionSellingGeneralAndAdministrativeExpensesFromTransactionsWithRelatedParty
6000 USD
us-gaap Cost Of Property Repairs And Maintenance
CostOfPropertyRepairsAndMaintenance
9720 USD
CY2013Q3 us-gaap Preferred Stock Redemption Premium
PreferredStockRedemptionPremium
726378 USD
CY2013Q3 isr Gross Proceeds From Issuance Of Stock
GrossProceedsFromIssuanceOfStock
3703527 USD
CY2013Q3 isr Payments For Underwriting Fees Costs
PaymentsForUnderwritingFeesCosts
185176 USD
CY2013Q3 isr Payments Of Stock Issuance Costs Legal And Accounting Expense
PaymentsOfStockIssuanceCostsLegalAndAccountingExpense
184514 USD
dei Document Type
DocumentType
10-Q
dei Amendment Flag
AmendmentFlag
false
dei Entity Registrant Name
EntityRegistrantName
IsoRay, Inc.
dei Document Period End Date
DocumentPeriodEndDate
2014-12-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--06-30
dei Entity Filer Category
EntityFilerCategory
Smaller Reporting Company
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2015
dei Entity Central Index Key
EntityCentralIndexKey
0000728387
CY2013Q3 isr Payments Of Stock Issuance Costs Listing Expense
PaymentsOfStockIssuanceCostsListingExpense
48500 USD
CY2013Q3 isr Payments Of Stock Issuance Costs Other Expenses
PaymentsOfStockIssuanceCostsOtherExpenses
6045 USD
CY2013Q3 us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
3279292 USD
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
51786 USD
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
252308 USD
CY2013Q3 us-gaap Deferred Compensation Arrangement With Individual Fair Value Of Shares Issued
DeferredCompensationArrangementWithIndividualFairValueOfSharesIssued
6906 USD
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
42907 USD
CY2014Q4 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
21453 USD
CY2013Q4 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
13432 USD
CY2014Q4 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
297591 USD
CY2014Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
672597 USD
CY2014Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue
644927 USD
CY2014Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
645947 USD
CY2014Q4 us-gaap Inventory Raw Materials
InventoryRawMaterials
191581 USD
CY2014Q4 us-gaap Inventory Work In Process
InventoryWorkInProcess
191229 USD
CY2014Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
28610 USD
CY2014Q4 us-gaap Inventory Net
InventoryNet
411420 USD
CY2014Q2 us-gaap Inventory Net
InventoryNet
359737 USD
CY2014Q2 us-gaap Inventory Finished Goods
InventoryFinishedGoods
34999 USD
CY2014Q2 us-gaap Inventory Work In Process
InventoryWorkInProcess
151321 USD
CY2014Q2 us-gaap Inventory Raw Materials
InventoryRawMaterials
173417 USD
CY2013Q3 us-gaap Deferred Compensation Arrangement With Individual Fair Value Of Shares Issued
DeferredCompensationArrangementWithIndividualFairValueOfSharesIssued
25150 USD
CY2014Q4 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-909612 USD
CY2013Q4 us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
2658 USD
CY2013Q4 us-gaap Preferred Stock Redemption Premium
PreferredStockRedemptionPremium
USD
CY2013Q4 us-gaap Net Income Loss
NetIncomeLoss
-926972 USD
CY2013Q4 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
117395 USD
CY2013Q4 us-gaap Interest Expense
InterestExpense
86 USD
CY2013Q4 us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
117000 USD
CY2013Q4 us-gaap Investment Income Interest
InvestmentIncomeInterest
481 USD
CY2013Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
-1044367 USD
CY2013Q4 us-gaap Operating Expenses
OperatingExpenses
1010461 USD
CY2013Q4 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
513964 USD
CY2013Q4 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
326467 USD
CY2013Q4 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
170030 USD
CY2013Q4 us-gaap Cost Of Goods Sold
CostOfGoodsSold
1119314 USD
CY2013Q4 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
1085408 USD
us-gaap Adjustment For Amortization
AdjustmentForAmortization
15469 USD
us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
347000 USD
us-gaap Asset Retirement Obligation Accretion Expense
AssetRetirementObligationAccretionExpense
39734 USD
us-gaap Share Based Compensation
ShareBasedCompensation
42907 USD
isr Supplemental Common Stock Warrant Liability Reclassification
SupplementalCommonStockWarrantLiabilityReclassification
-17000 USD
isr Noncash Investing And Financing Items
NoncashInvestingAndFinancingItems
17000 USD
us-gaap Depreciation And Amortization
DepreciationAndAmortization
305147 USD
us-gaap Increase Decrease In Restricted Cash
IncreaseDecreaseInRestrictedCash
27 USD
us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
70411 USD
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
145274 USD
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
205053 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-6343220 USD
isr Provision For Reduction Of Doubtful Accounts
ProvisionForReductionOfDoubtfulAccounts
8607 USD
us-gaap Proceeds From Issuance Of Preferred Stock And Preference Stock
ProceedsFromIssuanceOfPreferredStockAndPreferenceStock
USD
us-gaap Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
USD
us-gaap Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
USD
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
1562 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
14419 USD
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-1738002 USD
us-gaap Increase Decrease In Other Employee Related Liabilities
IncreaseDecreaseInOtherEmployeeRelatedLiabilities
-2646 USD
us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
13663 USD
us-gaap Increase Decrease In Other Current Liabilities
IncreaseDecreaseInOtherCurrentLiabilities
24000 USD
us-gaap Increase Decrease In Other Accrued Liabilities
IncreaseDecreaseInOtherAccruedLiabilities
21668 USD
CY2014Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1336853 USD
us-gaap Net Income Loss
NetIncomeLoss
-1692816 USD
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
2296 USD
us-gaap Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
5058080 USD
us-gaap Payments To Acquire Longterm Investments
PaymentsToAcquireLongtermInvestments
4695282 USD
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-4790648 USD
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-16013 USD
us-gaap Net Income Loss
NetIncomeLoss
-2197878 USD
us-gaap Proceeds From Issuance Of Preferred Stock And Preference Stock
ProceedsFromIssuanceOfPreferredStockAndPreferenceStock
1478712 USD
us-gaap Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
1800580 USD
us-gaap Payments To Acquire Longterm Investments
PaymentsToAcquireLongtermInvestments
USD
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-2273 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-46515 USD
us-gaap Increase Decrease In Other Receivables
IncreaseDecreaseInOtherReceivables
-1438 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
20762 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-26641 USD
isr Provision For Reduction Of Doubtful Accounts
ProvisionForReductionOfDoubtfulAccounts
20083 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
1514645 USD
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
3268660 USD
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
USD
us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
USD
us-gaap Increase Decrease In Restricted Cash
IncreaseDecreaseInRestrictedCash
32 USD
us-gaap Depreciation And Amortization
DepreciationAndAmortization
349232 USD
isr Supplemental Common Stock Warrant Liability Reclassification
SupplementalCommonStockWarrantLiabilityReclassification
USD
us-gaap Payments Of Dividends Preferred Stock And Preference Stock
PaymentsOfDividendsPreferredStockAndPreferenceStock
10632 USD
us-gaap Proceeds From Sale Of Short Term Investments
ProceedsFromSaleOfShortTermInvestments
5013694 USD
CY2014Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
7680073 USD
us-gaap Share Based Compensation
ShareBasedCompensation
51786 USD
us-gaap Asset Retirement Obligation Accretion Expense
AssetRetirementObligationAccretionExpense
36326 USD
us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
81000 USD
us-gaap Adjustment For Amortization
AdjustmentForAmortization
15371 USD
us-gaap Proceeds From Sale Of Short Term Investments
ProceedsFromSaleOfShortTermInvestments
USD
us-gaap Payments Of Dividends Preferred Stock And Preference Stock
PaymentsOfDividendsPreferredStockAndPreferenceStock
10632 USD
CY2013Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
2899927 USD
CY2013Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
4414572 USD
CY2014Q4 us-gaap Short Term Investments
ShortTermInvestments
10047298 USD
CY2014Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
30000 USD
CY2014Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
797381 USD
CY2014Q4 us-gaap Other Receivables Net Current
OtherReceivablesNetCurrent
10978 USD
CY2014Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
221167 USD
CY2014Q4 us-gaap Assets Current
AssetsCurrent
12825097 USD
CY2014Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
761425 USD
CY2014Q4 us-gaap Long Term Investments
LongTermInvestments
10096680 USD
CY2014Q4 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
181235 USD
CY2014Q4 us-gaap Inventory Noncurrent
InventoryNoncurrent
469758 USD
CY2014Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
250903 USD
CY2014Q4 us-gaap Assets
Assets
24585098 USD
CY2014Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
488321 USD
CY2014Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
90380 USD
CY2014Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
108068 USD
CY2014Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
146745 USD
CY2014Q4 us-gaap Accrued Vacation Current
AccruedVacationCurrent
108378 USD
CY2014Q4 us-gaap Liabilities Current
LiabilitiesCurrent
941892 USD
CY2014Q4 us-gaap Derivative Liabilities Noncurrent
DerivativeLiabilitiesNoncurrent
209000 USD
CY2014Q4 us-gaap Asset Retirement Obligations Noncurrent
AssetRetirementObligationsNoncurrent
906294 USD
CY2014Q4 us-gaap Liabilities
Liabilities
2057186 USD
CY2014Q4 us-gaap Treasury Stock Value
TreasuryStockValue
8390 USD
CY2014Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
82224632 USD
CY2014Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-59743272 USD
CY2014Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
24585098 USD
CY2014Q4 us-gaap Preferred Stock Value
PreferredStockValue
59 USD
CY2014Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2014Q4 us-gaap Common Stock Value
CommonStockValue
54883 USD
CY2014Q2 us-gaap Preferred Stock Value
PreferredStockValue
59 USD
CY2014Q2 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
181208 USD
CY2014Q2 us-gaap Long Term Investments
LongTermInvestments
5401398 USD
CY2014Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1017915 USD
CY2014Q2 us-gaap Assets Current
AssetsCurrent
19214900 USD
CY2014Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
206047 USD
CY2014Q2 us-gaap Other Receivables Net Current
OtherReceivablesNetCurrent
53082 USD
CY2014Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
913049 USD
CY2014Q2 us-gaap Liabilities
Liabilities
2593487 USD
CY2014Q2 us-gaap Asset Retirement Obligations Noncurrent
AssetRetirementObligationsNoncurrent
866560 USD
CY2014Q2 us-gaap Derivative Liabilities Noncurrent
DerivativeLiabilitiesNoncurrent
573000 USD
CY2014Q2 us-gaap Liabilities Current
LiabilitiesCurrent
1153927 USD
CY2014Q2 us-gaap Accrued Vacation Current
AccruedVacationCurrent
120765 USD
CY2014Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
236282 USD
CY2014Q2 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
141592 USD
CY2014Q2 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
80433 USD
CY2014Q2 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
574855 USD
CY2014Q2 us-gaap Assets
Assets
26549255 USD
CY2014Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
264076 USD
CY2014Q2 us-gaap Inventory Noncurrent
InventoryNoncurrent
469758 USD
CY2014Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2014Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
26549255 USD
CY2014Q2 us-gaap Stockholders Equity
StockholdersEquity
23955768 USD
CY2014Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-58050456 USD
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-2929572 USD
us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
5316 USD
us-gaap Preferred Stock Redemption Premium
PreferredStockRedemptionPremium
726378 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
81008 USD
us-gaap Interest Expense
InterestExpense
827 USD
us-gaap Investment Income Interest
InvestmentIncomeInterest
835 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-2278886 USD
us-gaap Operating Expenses
OperatingExpenses
2167672 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1165000 USD
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
685652 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
317237 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
317020 USD
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
657526 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1113891 USD
CY2014Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
-1020314 USD
CY2014Q4 us-gaap Investment Income Interest
InvestmentIncomeInterest
72360 USD
CY2014Q4 us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
41000 USD
CY2014Q4 us-gaap Interest Expense
InterestExpense
USD
CY2014Q4 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
113360 USD
CY2014Q4 us-gaap Net Income Loss
NetIncomeLoss
-906954 USD
CY2014Q4 us-gaap Preferred Stock Redemption Premium
PreferredStockRedemptionPremium
USD
CY2014Q4 us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
2658 USD
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.08
CY2013Q4 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.02
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.03
CY2014Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
us-gaap Operating Expenses
OperatingExpenses
2088654 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-2181420 USD
us-gaap Investment Income Interest
InvestmentIncomeInterest
145055 USD
us-gaap Preferred Stock Redemption Premium
PreferredStockRedemptionPremium
USD
us-gaap Interest Expense
InterestExpense
3451 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
488604 USD
us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
5316 USD
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-1698132 USD
CY2014Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
81959853 USD
CY2014Q2 us-gaap Treasury Stock Value
TreasuryStockValue
8390 USD
CY2014Q2 us-gaap Common Stock Value
CommonStockValue
54702 USD
CY2014Q2 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
38607 USD
CY2014Q2 us-gaap Short Term Investments
ShortTermInvestments
10002912 USD
us-gaap Gross Profit
GrossProfit
-111214 USD
us-gaap Cost Of Goods Sold
CostOfGoodsSold
2246537 USD
us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
2135323 USD
us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
2107686 USD
us-gaap Cost Of Goods Sold
CostOfGoodsSold
2200452 USD
us-gaap Gross Profit
GrossProfit
-92766 USD
CY2013Q4 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-929630 USD
CY2014Q4 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
1065585 USD
CY2014Q4 us-gaap Cost Of Goods Sold
CostOfGoodsSold
1103549 USD
CY2014Q4 us-gaap Gross Profit
GrossProfit
-37964 USD
CY2014Q4 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
140627 USD
CY2014Q4 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
303783 USD
CY2014Q4 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
537940 USD
CY2014Q4 us-gaap Operating Expenses
OperatingExpenses
982350 USD
CY2014Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2014Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2014Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2014Q4 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.02
CY2013Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice
0.58
CY2013Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice
0.59
CY2013Q3 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
0.58
CY2014Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
2.00
CY2014Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
1.96
CY2013Q3 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
0.59
CY2014Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
1.98
CY2014Q4 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
1.22
isr Class Of Warrant Or Right Issued In Period Exercise Price Of Warrants Or Rights
ClassOfWarrantOrRightIssuedInPeriodExercisePriceOfWarrantsOrRights
1.45
CY2014Q2 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
1.43
CY2014Q2 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
444747 shares
CY2015Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
54883445 shares
CY2014Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
396574 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
13156388 shares
isr Issuance Of Common Stock In Connection With Warrant Exercises Net Of Issuance Costs Shares
IssuanceOfCommonStockInConnectionWithWarrantExercisesNetOfIssuanceCostsShares
48173 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
65000 shares
CY2013Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
15000 shares
CY2014Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
2057620 shares
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
133564 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
84236 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
39002 shares
CY2014Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
1821504 shares
CY2014Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
1988995 shares
CY2013Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
50000 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
2636497 shares
CY2014Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
7001671 shares
CY2014Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
192998329 shares
CY2014Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
54883445 shares
CY2014Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
13200 shares
CY2014Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
54883445 shares
CY2014Q2 us-gaap Treasury Stock Shares
TreasuryStockShares
13200 shares
CY2014Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
7001671 shares
CY2014Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
54701708 shares
CY2014Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
193000000 shares
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
54875749 shares
CY2013Q4 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
38419502 shares
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
37133875 shares
CY2014Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
54701708 shares
CY2014Q4 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
54883445 shares
CY2013Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
1.3231 pure
CY2013Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0185 pure
CY2013Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P5Y
CY2013Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P5Y
CY2013Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
1.3231 pure
CY2013Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0177 pure
CY2014Q4 isr Percentage Of Royalty Rate Payable
PercentageOfRoyaltyRatePayable
0.01 pure

Files In Submission

Name View Source Status
0001144204-15-010049-index-headers.html Edgar Link pending
0001144204-15-010049-index.html Edgar Link pending
0001144204-15-010049.txt Edgar Link pending
0001144204-15-010049-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xls Edgar Link pending
Financial_Report.xlsx Edgar Link pending
isr-20141231.xml Edgar Link completed
isr-20141231.xsd Edgar Link pending
isr-20141231_cal.xml Edgar Link unprocessable
isr-20141231_def.xml Edgar Link unprocessable
isr-20141231_lab.xml Edgar Link unprocessable
isr-20141231_pre.xml Edgar Link unprocessable
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
v400223_10q.htm Edgar Link pending
v400223_ex31-1.htm Edgar Link pending
v400223_ex31-2.htm Edgar Link pending
v400223_ex32.htm Edgar Link pending